![]() |
|
|
Vol. 285, Issue 2, 404-412, May 1998
Neurobiological Psychiatry Unit, Department of Psychiatry,McGill
University, Montreal, Quebec, Canada
Duloxetine is a dual serotonin (5-HT)/norepinephrine (NE) reuptake
blocker with antidepressant potential. In the present in vivo electrophysiological study, the changes in the function of the rat 5-HT and NE systems after 2- and 21-day administration of
duloxetine (20 mg/kg/day) were assessed in the dorsal hippocampus and
the dorsal raphe nucleus (DRN). The firing rate of DRN neurons was
decreased after 2 days of duloxetine, but returned to the control level
after 21-day administration. This recovery of firing rate was
presumably due to the desensitization of the DRN somatodendritic 5-HT1A autoreceptors found after long-term duloxetine
administration. Overall serotonergic tone was assessed by examining the
ability of the 5-HT1A antagonist WAY 100635 to alter
hippocampal firing. WAY 100635 increased hippocampal firing rates in
21-day treated rats to a greater extent than in 2-day treated or
control rats, suggesting that long-term administration induced an
increase in endogenous levels of 5-HT in postsynaptic regions. This
increase in 5-HT levels was accompanied by selective changes in the
5-HT and NE systems induced by long-term duloxetine administration, i.e., the desensitization of the alpha-2
adrenergic heteroreceptor on 5-HT terminals and the continued blockade
of the 5-HT transporters. In contrast, the sensitivity of the
alpha-2 adrenergic and terminal 5-HT1B
autoreceptors, as well as that of the postsynaptic 5-HT1A receptor after 21-day treatment was unchanged. Therefore, this study
demonstrates that duloxetine increases serotonergic tone in a limbic
forebrain structure and may therefore be effective in the treatment of
depression.
This article has been cited by other articles:
![]() |
K. Tachibana, M. Matsumoto, H. Koseki, H. Togashi, T. Kojima, Y. Morimoto, and M. Yoshioka Electrophysiological and neurochemical characterization of the effect of repeated treatment with milnacipran on the rat serotonergic and noradrenergic systems J Psychopharmacol, July 1, 2006; 20(4): 562 - 569. [Abstract] [PDF] |
||||
![]() |
R. J. Lantz, T. A. Gillespie, T. J. Rash, F. Kuo, M. Skinner, H-Y. Kuan, and M. P. Knadler METABOLISM, EXCRETION, AND PHARMACOKINETICS OF DULOXETINE IN HEALTHY HUMAN SUBJECTS Drug Metab. Dispos., September 1, 2003; 31(9): 1142 - 1150. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Haddjeri, P. Blier, and C. de Montigny Long-Term Antidepressant Treatments Result in a Tonic Activation of Forebrain 5-HT1A Receptors J. Neurosci., December 1, 1998; 18(23): 10150 - 10156. [Abstract] [Full Text] [PDF] |
||||